- 全部删除
您的购物车当前为空
Alogliptin (SYR-322) 是一种具有选择性口服活性的DPP-4的抑制剂,IC50值小于 10 nM,比对 DPP-8 和 DPP-9 的抑制性高 10000 倍以上,可研究 2 型糖尿病。

Alogliptin (SYR-322) 是一种具有选择性口服活性的DPP-4的抑制剂,IC50值小于 10 nM,比对 DPP-8 和 DPP-9 的抑制性高 10000 倍以上,可研究 2 型糖尿病。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 100 mg | ¥ 99 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 99 | In stock |
Alogliptin 相关产品
| 产品描述 | Alogliptin (SYR-322)(SYR-322) is a potent, selective inhibitor of DPP-4 with IC50 of <10 nM, exhibits greater than 10, 000-fold selectivity over DPP-8 and DPP-9. |
| 靶点活性 | DPP4:<10 nM |
| 别名 | 阿洛利停, 阿格列汀, SYR-322 |
| 分子量 | 339.39 |
| 分子式 | C18H21N5O2 |
| CAS No. | 850649-61-5 |
| Smiles | Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O |
| 密度 | 1.342 g/cm3 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 68 mg/mL (200.36 mM), Sonication is recommended. H2O: 2 mg/mL (5.89 mM), Sonication is recommended. Ethanol: 60 mg/mL (176.79 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||||||||||||
H2O/Ethanol/DMSO
Ethanol/DMSO
| |||||||||||||||||||||||||||||||||||||||||
评论内容